BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36170228)

  • 1. Gene expression profiling identifies candidate biomarkers for new latent tuberculosis infections. A cohort study.
    Herrera M; Keynan Y; McLaren PJ; Isaza JP; Abrenica B; López L; Marin D; Rueda ZV
    PLoS One; 2022; 17(9):e0274257. PubMed ID: 36170228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of long non-coding RNAs in peripheral blood mononuclear cells response to tuberculosis in children.
    Zhong X; Lei S; Lin JW; Ren M; Shu M
    Medicine (Baltimore); 2022 Oct; 101(42):e31065. PubMed ID: 36281118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular signatures distinguishing active from latent tuberculosis in peripheral blood mononuclear cells, after in vitro antigenic stimulation with purified protein derivative of tuberculin (PPD) or Candida: a preliminary report.
    Stern JN; Keskin DB; Romero V; Zuniga J; Encinales L; Li C; Awad C; Yunis EJ
    Immunol Res; 2009; 45(1):1-12. PubMed ID: 18648750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection.
    Wu J; Wang S; Lu C; Shao L; Gao Y; Zhou Z; Huang H; Zhang Y; Zhang W
    Tuberculosis (Edinb); 2017 Jan; 102():68-75. PubMed ID: 28061954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Risk Factors Associated with Latent Tuberculosis Infection and Pulmonary Tuberculosis among People Deprived of Liberty in Colombian Prisons.
    Herrera M; Keynan Y; López L; Marín D; Arroyave L; Arbeláez MP; Vélez L; Rueda ZV
    Am J Trop Med Hyg; 2021 Dec; 106(1):66-74. PubMed ID: 34872056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reprogramming of Small Noncoding RNA Populations in Peripheral Blood Reveals Host Biomarkers for Latent and Active Mycobacterium tuberculosis Infection.
    de Araujo LS; Ribeiro-Alves M; Leal-Calvo T; Leung J; Durán V; Samir M; Talbot S; Tallam A; Mello FCQ; Geffers R; Saad MHF; Pessler F
    mBio; 2019 Dec; 10(6):. PubMed ID: 31796535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of unique key genes and miRNAs in latent tuberculosis infection by network analysis.
    Lin Y; Zhang Y; Yu H; Tian R; Wang G; Li F
    Mol Immunol; 2019 Aug; 112():103-114. PubMed ID: 31082644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
    Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
    Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional Profiling of Human Peripheral Blood Mononuclear Cells Identifies Diagnostic Biomarkers That Distinguish Active and Latent Tuberculosis.
    Wang S; He L; Wu J; Zhou Z; Gao Y; Chen J; Shao L; Zhang Y; Zhang W
    Front Immunol; 2019; 10():2948. PubMed ID: 31921195
    [No Abstract]   [Full Text] [Related]  

  • 10. Malnutrition leads to increased inflammation and expression of tuberculosis risk signatures in recently exposed household contacts of pulmonary tuberculosis.
    VanValkenburg A; Kaipilyawar V; Sarkar S; Lakshminarayanan S; Cintron C; Prakash Babu S; Knudsen S; Joseph NM; Horsburgh CR; Sinha P; Ellner JJ; Narasimhan PB; Johnson WE; Hochberg NS; Salgame P
    Front Immunol; 2022; 13():1011166. PubMed ID: 36248906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda.
    Biraro IA; Kimuda S; Egesa M; Cose S; Webb EL; Joloba M; Smith SG; Elliott AM; Dockrell HM; Katamba A
    PLoS One; 2016; 11(1):e0146098. PubMed ID: 26771653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of Differentially Expressed Immune Biomarkers in Latent and Active Tuberculosis by Real-Time PCR.
    Perumal P; Abdullatif MB; Garlant HN; Honeyborne I; Lipman M; McHugh TD; Southern J; Breen R; Santis G; Ellappan K; Kumar SV; Belgode H; Abubakar I; Sinha S; Vasan SS; Joseph N; Kempsell KE
    Front Immunol; 2020; 11():612564. PubMed ID: 33841389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional Profiling and Deriving a Seven-Gene Signature That Discriminates Active and Latent Tuberculosis: An Integrative Bioinformatics Approach.
    Natarajan S; Ranganathan M; Hanna LE; Tripathy S
    Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis.
    Auguste P; Tsertsvadze A; Pink J; Court R; McCarthy N; Sutcliffe P; Clarke A
    BMC Infect Dis; 2017 Mar; 17(1):200. PubMed ID: 28274215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative latent tuberculosis at time of incarceration: identifying a very high-risk group for infection.
    Arroyave L; Keynan Y; López L; Marin D; Arbeláez MP; Rueda ZV
    Epidemiol Infect; 2017 Sep; 145(12):2491-2499. PubMed ID: 28756786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of Tuberculin Skin Test (TST) and T-SPOT.TB Tests for Diagnosis of Latent Tuberculosis Infection (LTBI) in HIV-infected Patients].
    Binay UD; Fincancı M; Fersan E; Karakeçili F
    Mikrobiyol Bul; 2019 Oct; 53(4):388-400. PubMed ID: 31709936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation Phenotype of
    Luo Y; Xue Y; Mao L; Lin Q; Tang G; Song H; Liu W; Tong S; Hou H; Huang M; Ouyang R; Wang F; Sun Z
    Front Immunol; 2021; 12():721013. PubMed ID: 34512645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.
    O'Shea MK; Fletcher TE; Beeching NJ; Dedicoat M; Spence D; McShane H; Cunningham AF; Wilson D
    PLoS One; 2014; 9(5):e97366. PubMed ID: 24816576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of latent tuberculosis infection among pre-clinical and clinical medical students using QuantiFERON-TB gold plus and tuberculin skin test at a teaching hospital in Thailand: A cross-sectional study.
    Chumpa N; Kawkitinarong K; Wongpiyabovorn J; Paitoonpong L; Suwanpimolkul G
    J Infect Public Health; 2022 Apr; 15(4):400-405. PubMed ID: 35325687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    Sun Q; Wei W; Sha W
    PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.